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Fusidic acid .is unusual amongst antimicrobial agents, and 
especially amongst those which inhibit protein synthesis, 
in having a steroid structure '.Vazquez 1979). Though diverse 
microorganisms a.-.'e able to perform bioconversion of steroids, 
nocardiofortK bacteria are notable for their ability ta 
effect m .ny different types of transformation of steroid 
molecules. This ability is being exploited to obtain 
compounds which are difficult to prepare by chemical 
synthesis but are of pharmacological importance, as 
intermediates in the synthesis of anti-inflammatory agents 
or oral contraceptives. The observation that nocardioform 
bacteria transform steroid compounds ties in with my study 
to explore the response of these organisms to the steroid 
fusidic acid.
Fusidic acid sequesters factor EF-G and GDP on the ribosome 
following a single round of GTP hyrolysisi it thus stabilizes 
what is normally an unstable ternary complex and leads 
to inhibition of protein synthesis. The drug does not 
interact primarily with ribosomes and no mutants with fusidic 
acid resistant ribosomes as opposed co EF-G have been 
reported (Reynolds, 1984).
An examination of the available amino acid sequences of 
GTP-binding proteins has revealed that each contains a 
polypeptide essentially homologous ior all of them. These 
sequences for elongation factor EF-TU and the human bladder 
protein, oncogene or proto-oncogene, p 21 exhibit a singular 
degree of homology 50% (Leberman et al,, 1984; Scolnick
et al., 1979; Shih et al., 1980; Papageorge et al., 1982).
Ihete is a high degree of homology between the N-terminal 
sequences of EF-G and ET-Tu suggesting an evol'itionary 
relationship between the two proteins (Jones et al., 1980). 
Conservation of functional regions in EF-G and EF-Tu suggests 
that the genes tor the two factors are at least in part 
derived from a common ancestor (Sacedot et al., 1984). 
Proteins which exhibit this high specific affinity for 
the guanosine nucleotides GTP and GDP are a diverse group. 
They include polypeptide elongation factors (EF-G, EF-Tu), 
tubulin, transducin and receptor protein of eukaryotic 
adenylate cyclase. It can thus be said that EF-G to some 
extent is homologous to oncogenes in GTP hydrolysis whose 
activity is also controlled by steroids, in particular 
protein p21 and its oncogenic variants.
A 56-year-old man with AIDS improved clinically after the 
introduction of fusidic acid, 500 mg 3 times a day orally, 
to his therapeutic regimen. Fusidic acid may have had a 
direct effect against human immunodeficiency virus (HIV). 
Fusidic acid has anti-HIV activity in vitro at levels readily 
attainable in vivo. The drug does not appear to be a re/erse 
transcriptase inhibitor and its mode of a^ian against 
HIV is not known. Fusidic acid can be given . -ally and 
has few side-effects. These results justify fuller evaluation 
of fusidic acid as therapy against AIDS and HIV Infection 
(Faber et al,, 1987).
Fusidic acid resistance / sensitivity can be altered due 
to the following circumstances:
(a) Differences in the permeability or the uptake of the 
antibiotic.
(b) Alteration in the target moiety EP-G.
(c) Presence/absence of the inactivating enzyme.
Loss of the inactivating enzyme was the point of interest 
for this work. The first step therefore was to create mutants 
that have lost the inactivating enzyme system, i.e. have 
mutational alteration of the gene/s coding for the enzyme.
The method I will employ for cloning the inactivation gene/s 
will be cloning by complementation which is by far the 
easiest way to clone genes. The first objective was to 
obtain fusidic acid hypersensitive mutants from the wild- 
type strain 01. These muta: cs may have mutati " l' ation
of the gene/s involved in the fusidic acid  u.ivation
system, and are thus -.o longer able to inactivate fusidic 
acid as the wi’ type strain can. Also a number of 
hypersensitive mutants were needed, as the various
complementation groups gov 1 ! thus be examined to give a 
better idea as to how r gene/s are involved in the 
Inactivation mechanism. The fusidic acid hypersensitive
mutants would be obtained by doing mutagenesis experiments 
with a n-tzsber of different mutagens, in pari.'cular 
nitrosoguanidine {NTG). Mutagenesis conditions b, j to
be optimised. The fusidic acid hypersensitive mutant, would 
be used as recipients into which chromosomal DMA rim a 
related organism not having mutational alterations o *;!ie 
gene/s involved in coding for the antibiotic ina.-' -.on 
system, would be transformed.
This chromosomal DMA would Chen complemenC Che hypersensicive 
mutants resulting in a genocype thaC could once again 
inactivaci fusidic acid. Nocardioform 14887/1 ( ocardia
rescricca, also called Rhodococcus equi) chromosomal DMA 
was used in order to minimise recombination when this was 
transformed into 01, as no rec recipienC nocardioform 
serein was available.
It was therefore necessary to build up a genomic library 
of 14887/1 chromosomal DMA in Escherichia coli strain MM 
294-1. This would then be used for transforming the fusidic 
acid hypersensitive mutants. A putative shuttle vector 
derived from joining a nocardioform arsenic resistance 
plasmid pDA22 and a coli plasmid pEcoR251 with ampicillin 
resistance joined at the BamHl restriction site, was used 
as the vector for transforming MM 294-1 with the 14887/1 
chromosomal DNA. Chromosomal DNA fragments were inserted 
into the EcoR 1 gene of the pEcoR251 plasmid by using the 
restriction endonuclease Bgl II, as there is only one Bgl 
II site within the putative shuttle vector and this is 
in the EcoR 1 gene. pEcoR251 being a suicide vector it 
would be easy to screen for transformants, as only those 
colonies growing on selective plates containing the 
appropriate concentration of ampicillin to which the putative 
shuttle vector is resistant are transformants. This is 
because the inserted chromosomal DNA fragments have caused 
insertional inactivation of the EcoR 1 gene activity,
The purpose of my work was to work towards the cloning 
of gene/s encoding the fusidic acid inactivation mechanism 
in nocarioform bacteria, and this could be achieved by 
complementation, in which case the putative shuttle vector 
containing the 14687/1 chromosomal DNA inserts constituting 
a genomic library of the organism, would be transformed 
into the fusidic acid hypersensitive mutants, thereby 
complementing the lack of fusidic acid inactivation in 
these mutants. It would then be simple to select for those 
colonies or transformants that have the inactivation gene/s, 
as only these colonies will grow on selective plates 
containing the appropriate concentration of fusidic acid.
:ythropoli;
Ol(pro')
A screptomycii 
A rifampicin •
A rifampii
pDA22 joined to the 
coll plasmid pEcoR251.
pEcoR251
lysogen.
.2. GROWTH AND MAINTENANCE OF STRAINS USED
All nocardioform strains were grown in T2 medium (see 
Appendix) at 28°C. Strains were maintained on TYA 
plates I see Appendix) and stored at a temperature 
of 4°C. For long t=>rra storage strains were placed 
in 33% glycerol and stored at -80eC.
Escherichia coli strains were grown in LB medium (see 
Appendix) at 37°C and maintained on LA plates i see 
Appendix). LA plates were also stored at 4°C, for 
long term storage 33% glycerol was again used and 
stored at -80°C.
.3. DETERMINATION OF RESISTANCE 
(Dabbs E.R., Sole G.J., 1987)
The resistance levels of all the strains tested to 
antibiotics and other compounds were measured by 
spotting on TYA or LA plates using a replicator. The 
highest concentration at which growth was confluent 
was taken to be the resistance level. Aliquots of 
stock solutions of antibiotics or other compounds 
were added to plate media after autoclaving and before 
pouring. All strains used in these assays were firstly 
streaked to single colonies to ensure accuracy and 
reproducibility of results. Plates were incubated 
at 28°C for 72 hours before being assayed.
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ASSAYING FOR FUSIDIC ACID INACTIVATION BY NOCARD10FORM 
BACTERIA'
The assay plates were 25 ml LA plus 30 /ll/ml 
rifampicin. A 1" mg/ml stock solution of rifampicin 
was prepared in methanol. The inhibitory effect of 
fusidic acid in solution was monitored by measuring 
the zones of inhibition on a lawn of C7R, the assay 
organism used. 0.1 ml of a fresh C7R culture was
spread on a plate, and 60 ftl aliquots of culture 
or supernatant depending on the assay were pipetted 
into wells cut into the agar with the broad end of 
a Pasteur pipette. The culture to be assayed was 
always prepared from a fresh preculture by making 
a 1 in 25 dilution into 5 ml of fresh T2 medium.
This culture was then allowed to grow for 3 - 4  hours 
at 28°C before being challenged with fusidic acid 
of the required concentration. Fusidic acid was 
obtained from LEO Pharmaceuticals, and 10 mg/ml 
stock solutions were prepared in 961 ethanol. Plates 
were incubated at 28° C for 24 hours before being
ANTIBIOTIC INACTIVATION BY CELL-FREE SUPERNATANTS 
Cell-free supernatants were obtained by centrifuging 
1 ml aliquots of culture in EppendCrf tubes for 1 
minute. The supernatant was then transferred to a
/
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new Eppendorf tube and 20 pg/ml rifampiein was added 
instead_ of fi-ner sterilizing to avoid any growth 
in the supernatant due to the carry over of 
contaminating cells. Fusidic acid to a final 
concentration of 40 /ig/mi was then added. This solution 
was allowed to incubate at 37°C for 24 hours before 
the 60 ,ul samples were loaded into the wells of the 
assay plates spread with a lawn of C7R.
.2 LIQUID ASSAY OF FUSIDIC ACID INACTIVATION BOTH BY 
ACTIVELY GROWING CULTURE AND BY CELL-FREE SUPERNATANT 
A preculture of the organism/s to be assayed was 
prepared. 500 ul of preculture was then used to in­
oculate 10 ml of fresh T2 medium which was allowed 
to grow at 28eC for 5-6 hours, before optical density 
(OD) readings were taken and standardized. Once the 
OD readings of all strains to be assayed were adjusted 
to the same absorption, cultures were challenged 
with the required fusidic acid concentration, and 
this was taken as zero time. The OU’s of the cultures 
were taken at 0,2,4,6 and 8 hours. After each reading 
2 ml aliquots of each culture were taken and centri­
fuged for 1 rain in a microfuge. The supernatants 
were then pipetted into fresh Eppendorfs and heated 
to 95°C for 5 rain to inactivate the fusidic acid 
inactivating enzyme/s. The supernatants can then 
be frozen at -80°C. In this assay the supernatants 
are not assayed on plates as mentioned in 2.4.1,
but i. are aliquoted into LB containing a 1 in 100 
dilution of C7R. 1 ml of supernatant was added to 
4 ml of LB with 20 jug/ml rifampicin in autoclaved 
test tubes. Rifampicin was added in an attempt to 
prevent contamination by organisms other than the 
assay organism C7R. 1 ml of various concentrations 
of fusidic acid made in T2 medium were also aliquoted 
into 4 ml LB with 20 /ug/ml rifampicin and these were 
used as standards to give an idea of the concentration 
of fusidic acid left after a given time i.e. the 
concentecation of fusidic acid which has not been 
inactivated. All the test tubes were then incubated 
at 28°C and allowed to grow up on a revolving wheel. 
Oner the cultures became turbid the OD readings were
2.5. OBTAINING HIGH LEVEL RESISTANCE MUTANTS 
High level antibiotic resistant mutants were obtained by 
spreading 1 ml aliquots of the culture of the particular 
organism onto TYA plates containing 100 /ig/ml of the 
antibiotic or compound to which the resistance was to be 
made. Plates were then incubated at 28°C until colonies 
appeared. Each colony was then streaked to single colonies 
on a fresh TYA plate containing 50 ^ug/ml of the antibiotic 
or compound and maintained as such at 4°C.
2.6. HITROSOGUABIDIttE (NTG) AND BTHYLMETHAMESULPHONATE 
(EMS) MUTAGENESIS 
Strains were grown up in 5 ml T2 overnight. NTG was mat.e 
up by dissolving 2 mg into 2 ml of buffer. The buffer used 
was a Tris-HCl buffer for pH 8 and a Tris maleate buffer 
for pH 4.8. A 2% EMS solution was prepared by dissolving 
40 ul of EMS in 2 ml of Tris-HCl buffer pH 7.0. 0,1 ml
of the overnight culture was pelleted for 20 seconds and 
the pellet was washed in the respective buffers. For NTG, 
the cells were resuspended in 0,9 ml buffer and 0,1 ml 
NTG to give a final NTG concentration of 100 /ug/ml. For 
EMS mutagenesis, cells were resuspended in 1 ml of the 
EMS solution. These suspensions were left at 37°C for 2 
hours, after which they were again pelleted for 10 seconds. 
The cells were washed in sterile distilled water and pelleted 
again for 10 seconds. Cells were resuspended in 100 )^1 
T2 medium. The 100 u^l of cells were then aliquoted into 
an autoclaved flask containing 5 ml T2 medium, 100 ug/ml 
streptomycin was added to this. A 10 mg/ml streptomycin 
stock was prepared in SOS sterile distilled water and 50% 
of 96% ethanol. The culture was allowed to outgrow at 28°C 
after which it was sonicated for 5 seconds to reduce the 
clumping of cells. The culture was then diluted to a 
concentration of 10 6, and 100 .^il aliquots of this dilution 
were spread onto TYA plates. Plates were incubated at 28°C 
until colonies appeared. These colonies were patched onto 
TYA plates of varying concentrations of fusidic acid to 
ensure that mutants were indeed fusidic acid sensitive.
To test the efficiency of mutagenesis colonies were patched 
onto minimal ' media (MM) plates {see Appendix) to check 
for auxotrophs.
2.6.1 MUTAGENESIS OF EXPONENTIALLY GROWING STRAINS
2 ml of exponentially growing cells were taken to which
3 ml of T2 medium was added to give a final volume of 5ml. 
NTS at pH 4.8 and pH 8 was then added to a final 
concentration of 100 jug/ml. Growth was continued for 1
hour at 28°C. Cells were pelleted and resuspended in 5
ml T2 medium, in this instance cells were not washed with 
the respective buffer. The culture was allowed to grow 
for several hours before 100 pg/ml streptomycin was added. 
Again the culture was sonicated for 5 seconds to reduce 
clumping of cells and diluted to 10 ®. The 10 6 culture 
was vortexed for 80 seconds before 100 ^ul aliquots were
spread onto TYA plates. Again plates were incubated at 
28”C until colonies appeared. Colonies were again patched 
onto TYA, TYA + fusidic acid, and MM plates.
2.6.2 ENHANCEMENT OP NTG MUTAGENESIS BY CHLORAMPHENICOL 
(MISHRA, TIVARX, 1985)
A culture was grown overnight in T2 medium. 250 yul of this 
culture was then spun down and resuspended in 5 ml of TY 
medium (see Appendix). This was allowed to shake at 28°C 
for 6 hours until the culture was in exponential phase, 
and then 100 /.ig /ml of NTG pH 4.8 was added to one flask
and 100 yg/ml NTfl pH 4.8 plus 200 fug/ml chloramphenicol 
was added to • another flask and put at 28°C for 2 hours. 
TY medium was used rather than T2 medium as calcium seem 
to enhance killing by chloramphenicol. After the 2 hour 
incubation 1 ml of each sample was spun down washed with 
sterile distilled water pelleted again and resuspended 
in 5 ml T2 to allow for phenotypic expression. After 
outgrowth the cultures were again sonicated for 5 seconds 
to reduce clumping and diluted to 10 The 10 ®
dilutions were vortexed for 80 seconds and 100 ul aliquots 
were spread onto TYA plates. Plates were incubated at 28°C 
as before. The resulting colonies were patched onto TYA, 
TYA + 1 fag/ml fusidic acid, and MM plates to screen for 
fusidic acid sensitive mutants.
2.6.3 ACBIDINE ORANGE AMD ETHIDIOM BROMIDE (EtBr) MUTAGENESIS 
A culture was grown to stationery phase after which 5 /ul 
of the culture was aliquoted into 5 ml of T2 medium into 
3 seperate flasks, to one flask 5 yug/ml acridine orange, 
to another 10 yug/ml and to the third 15 ug/ml was added 
and allowed to grow. The same protocol was followed for 
EtBr. Acridine orange was dissolved in sterile distilled 
water, filter sterilised and kept in the dark at 4°G. EtBr 
was prepared in the same way. Once outgrown the cultures 
were sonicated for 5 seconds and diluted to .10 6 . The dilution 
was vortexed for 80 seconds before 100 /ul aliquots were 
spread onto TYA plates. Plates were incubated at 286C until 
colonies appeared. Again colonies were patched onto TYA, 
TYA + 1 jUg/ml fusidic acid and MM plates. All strains used
/
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and 100 (ug/ml NTG pH 4.8 plus 200 ^ug/ml chloramphenicol 
was added to - another flask and put at. 28°C for 2 hours. 
T¥ medium was used rather than T2 medium as calcium seem 
to enhance .-.illing by chloramphenicol. After the 2 hour 
incubation 1 ml of each sample was spun down washed with 
sterile distilled water pelleted again and resuspended 
in 5 ml T2 to allow for phenotypic expression. After 
outgrowth the cultures were again sonicated for 5 seconds 
to reduce clumping and diluted to 10-6. The 10 6 
dilutions were vortexed for 80 seconds and 100 ul aliquots 
were spread onto TYA plates. Plates were incubated at 28eC 
as before. The resulting colonies were patched onto TYA, 
TYA + 1 /ug/ml fusidic acid, and MM plates to screen for 
fusidic acid sensitive mutants.
2.6.3 ACRIDIHE ORANGE AND E 1,’HIDIOM BROMIDE (EtBr) MUTAGENESIS 
A culture was grown to stationery phase after which 5 fj.1 
of the culture was aliquoted into 5 ml of T2 medium into 
3 sseperate flasks, to one flask 5 jug/ml acridine orange, 
to another 10 ,ug/ml and to the third 15 ug/ml was added 
and allowed to grow. The same protocol was followed for 
EtBr. Acridine orange was dissolved in sterile distilled 
water, filter sterilised and kept in the dark at 4eC. EtBr 
was prepared in the same way. Once outgrown the cultures 
wsre sonicated for 5 seconds and diluted to .lO”6. The dilution 
was vortexed for 80 seconds before 100 /ul aliquots were 
spread onto TYA plates. Plates were incubated at 28°C until 
colonies appeared. Agai- colonies were patched onto TYA, 
TYA + 1 /ug/ml fusidic acid and MM plates. All strains used
for mutagenesis were made either rifampicin or streptomycin 
resistant and • depending on which strain was used rifampicin 
or streptomycin was added to prevent contamination while 
cells were being outgrown.
2.6.4 ULTRAVIOLET (UV) MUTAGENESIS
A culture was grown up overnight, the culture was then 
sonicated for 5 seconds. The sonicated culture was diluted 
to a final concentration of 10 \  A 200 i^l drop of 
this 10  ^ dilution was then placed onto the surface 
of a sterile petri-dish and -xposed to UV radiation for 
varying periods of time. After each time period 10 Ml of 
the droplet was added to a drop of sterile distilled water 
on a TYA plate and spread. The TYA plates were then incubated 
at 28°C in the dark for 2 days. A control plate was compared 
to the other TYA plates onto which were spread the samples 
of varying exposure to UV light. The colonies on the plate 
exhibiting the most killing due to UV radiation were patched 
onto TYA and MM plates as before to screen for mutants.
2.7. BULK PREPARATION OF DMA (BOTH PLASMID AMD 
CHROMOSOMAL) FROM NOCARDIOFORM BACTERIA 
The organism was grown in 250 ml TYG (see Appendix) when 
chromosomal DNA was to be extracted and in 250 ml TYG + 
20 mM arsenate when plasmid was to be purifiM. Arsenate 
was added to maintain the plasmid which has arsenic 
resistance. The cells were harvested at 6000 rpm for 20
minutes in a Beckman J2 - 21 r.ifuge, and resuspended
in 10 ml of lOmM Tris pH 8, 10% sucrose. 50 - 100 mg lysozyme 
was added to this suspension in 5 ml of the same buffer. 
This was incubated at 37°C for 2 hours. Cells were pelleted 
at 12 000 rpm for 15 minutes and resuspended in 8 ml TK 
(see Appendix) to which 0.8 ml TE containing 10% sodium 
dodecyl sulphate (SDS) was added. This was incubated at 
37°C for 2 houvS. The sample was then loaded into 50Ti 
tubes and spun for 30 minutes at 35 000 rpm in a Beckman 
L5-55 ultracentifuge. The DNA solution was decanted and 
8 - 9 g caesium chloride (CsCl) was added and dissolved. 
The solution was centrifuged at 13 000 rpm for 15 minutes, 
the DNA solution was decanted out from under the scum which 
had formed. The refractive index of the DNA solution was 
me a s u r e a n d  a justed to 1.392 for plasmid DNA and 1.390 
for chromosomal DMA respectively. 0.1 ml BtBr was added 
per ml of solution. The solution was loaded into quickseal 
ultracentrifuge tubes which were balanced and sealed and 
centrifuged overnight at 45 000 rpm in a VTi65.2 vertical 
rotor. The plasmid or chromosomal bands were extracted 
and pooled, reloaded in an ultracentrifuge tube which was 
filled with CsCl at a concentration of i g/ml in TE. The 
tube was respun overnight. The plasmid or chromosomal band 
was again extracted and treated with TE saturated butanol 
to removp E*:Br by inverting the Eppendorf tube several 
times and then separating the two phases by a 30 second 
centrifugation in a microfuge. The istBr partitions into 
the upper butanol phase which is removed using a Pasteur 
pipette. The sample was then dialysed against TE
for 3-4 hours to eliminate CsCl. The DMA concentration 
was ascertained by measuring the absorbance at 260nm and 
the sample which was now in TE was frozen at -80°C.
2,8 BULK PLASMID PREPARATION (E.coli)
(Clewell? Helsinki, 1968)
The organism was grown overnight in 200-300 ml LB containing 
10 mM magnesium sulphate and 50 /ig/ml ampicillin to maintain 
the plasmid. Cells were pelleted at 6 000 rpm for 10 minutes 
and resuspended in 10 ml cold TE. Cells were again pelleted 
at 6 000 rpm for 10 minutes, and resuspended in 2 ml cold 
25% sucrose, 50 mM Tris pH 8. 0.25 ml fresh lysozyme
solution (lOmg/ml) was added and this was gently swirled 
on ice for 15 minutes. 0.25 ml of 0.5 K BETA 
pH 8 was then added and this was swirled on ice for 5 
minutes. 2.5 ml of cold detergent solution (see Appendix) 
was added and' swirled on ice for 10 minutes until partial 
clearing was observed. The material was now highly viscous. 
This was centrifuged at 18 000 rpm for 45 minutes. The
supernatant was decanted and measured and for each ml of
supernatant 0.95 g of CsCl was added. 0.1 ml of EtBr was
now added (10 mg/ml in sterile water) per ml cleared lysate. 
The refractive index was measured and adjusted to 1.392. 
The sample was loaded into ultracentrifuge tubes which 
were sealed and balanced and spun overnight at 40 000 rpm
in a VT165.2 vertical rotor. Again EtBr was removed by 
using water saturated butanol and CsCl by dialysis against 
TE. The DNA concentration was ascertained and the sample 
frozen and stored at -80°C.
2.9. PLASMID MINIPREPARATION FOR SCREENING TRANSFORMANTS 
(Maniatis et al., 1952)
Transformants were grown in 4 ml LB + SO ^ug/ml ampicillin 
at 37°C overnight. 1 ml of the culture was harvested by 
a 1 minute centrifugation in a microfuge. The pellet was 
resuspended in 100 /al of solution 1 (see Appendix) and 
stood at room temperature for 5 minutes. 200 /ul of solution 
2 (see Appendix) was added and mixed gently and stood on 
ice for 5 minutes. 150 pi of precooled solution 3 (see
Appendix) was now added, mixed gently, and stood on ice 
for 5 minutes. The mixture was centrifuged for 1 minute 
and the supernatant pipetted into a sterile Eppendof tube. 
One volume of isopropanol was added to the supernatant
and allowed to stand at room temperature for 5 minutes. 
The DNA was then precipitated by centrifuging for 5 minutes. 
The pellet was washed with 961 ethanol and spun for 5 -
10 minutes in a microfuge. The ethanol was discarded and
the pellet was dried at 60 °C for 20 minutes. The dried 
pellet was resuspended in 12 yul TE + ribonuclease (10 mg/ml) 
at 42°C before samples were run on a 0.41 agarose gel.
2.10. PLASMID MINIPREPARATION FOR NOCARDIOFORM BACTERIA
(Dabbs and Sole; 1987)
5 ml overnight cultures of transformants in TYG + 50 mM 
arsenate were grown up in a flask at 28°C. 1 ml in each 
case was pelleted for 1 minute in a microfuge. SCO ul of 
Trissucrose containing 30 mg/ml lysozyme was used to 
resuspend the pellets. These suspensions were shaken for 
1 hour at 37eC. Cells were pelleted for 30 seconds and 
resuspended in 280 fil TE. 40 ul TE, 10% SDS was then added 
and tubes were incubated at 60°C for 10 minutes. 40 u^l
4.5 M sodium acetate was mixed in and samples were left 
on ice for 30 minutes. Suspensions were then microfuged 
for 20 minutes, the upper layer was pipetted into a new 
sterile Eppendorf tube. Samples were then treated once 
with 80 p.1 phenol and once with 80 yul chloroform: isoamyl 
alcohol (24:1). 2.5 volumes of cold ethanol was then added 
and samples microfuged for 20 minutes. Supernatants were 
discarded, and pellets dried for 20 minutes at 60*0. Dried 
pellets were resuspended in 20 /ul TE containing KNAse. 
After resuspending for 1 hour at 42°C samples were run 
on 0.4% agarose gels.
2.11. PREPARATION OF CHROMOSOMAL AND PLASMID DMA FOR 
LIGATION
The restriction endonuclease Bgl II was used to restrict 
both chromosomal and plasmid DNA. Chromosomal DMA was 
partially digested. To ascertain the optimal conditions 
for chromosomal DNA digestion a serial dilution of the 
restriction enzyme from 10'1 to 10~4 for 9 units/ul of 
the enzyme was made in (1 x) medium restriction buffer.
■i
1 /ul of each dilution was then added to chromosomal DMA 
that had been ethar.ol precipitated and resuspended in 90 
ul sterile distilled water and 10 fil (10 x) medium
restriction buffer at 42eC for 1 hour. Samples were
restricted at 37’c for 3 hours. Plasmid DMA was digested 
with 9 units/pl undiluted enzyme for 14 hours. After
restriction a phenol extraction was carried out before
ligation was performed to get rid of any remaining 
restriction endonuclease. An equal volume of phenol was
added and the samples spun for 10 minutes. The upper layer 
was pipetted into new sterile Eppendorf tubes and then 
equal volume of chloroform-isoamyl alcohol (24:1) was added, 
this was spun for 5 minutes. Again the top phase was pipetted
into new sterile Eppendorf tubes. An ethanol precipitation
was now performed. 2.5 volumes ice-cold ethanol and 1/10 
volume 1 m  NaCl was added to the samples. Samples were
spun for 20 minutes and dried for 20 minutes at 60°C. Dried 
pellets were resuspended in 100 jul ligation buffer (see 
Appendix) at 42°C for 1 hour. For ligations 50 jul ligation 
buffer was used to which the restricted chromosomal DNA, 
plasmid DNA, and T4 DNA ligase was added and allowed to 
incubate overnight at 14°C. In all cases 1 fil T4 DNA ligase 
was used, which is equivalent to 1 unit of this enzyme.
2.12. TRANSFORMATION OF NOCARDIOFORM STRAINS 
(Bibb et al.■ 1978)
An o-'ernight culture of 01 in TSfG was grown up at 48°C.
The optical density of the cells was then taken by diluting 
180 of cells to 720 {ul of TYG and reading the absorbance 
at 540 nm. 1 ml of the culture was then harvested by 
centrifuging for 1 minute in a microfuge. The pellet was 
resuspended in 1 ml of P-buffer (see Appendix) with 5 mg/ml 
lysozyme and incubated with agitation for 1 hour at 37°c.
The cells were again pelleted and resuspended gently in 
1 ml P-buffer, again cells were harvested and resuspended 
in 0.5 ml P-buffer. 75 /ul each of cells were then allquoted 
into two sterile Eppendorf tubes. To one tube which was
the control tube 5 fil TE was added while 5 /ul of plasmid 
pDA30 was added to the other. 80 jul polyethyleneglycol 
(PEG) made up by adding 1 g PEG to 1 ml P-buffer was then 
added to each Eppendorf tube. This was mixed gently and
left for 4-5 minutes. The samples were then spread onto
chilled regeneration plates (see Appendix) and incubated 
at 28°C. After a 12 hour incubation at 28°C an arsenic
underlay was done. 0.5 ml of a 3 M arsenate, 0.5 M arsenite 
solution was used for the underlay, giving a final molarity 
of 6 0mM arsenate, IGmM arsenite. Plates were incubated 
for approximately five days until colonies appeared.
2.13 TRANSFORMATION OF ESCHERICHIA COLI STRAIN MM294
(Daqert et ■»1., 1979; Norqard et al., 1978;
Maniatis et al., 1982)
100 ml of LB was inoculated with 1 ml of an overnight culture 
of nun 294 which was grown in LB at 37°C. The culture was 
allowed to grown for approximately 2 hours with vigorous
4 .
agitation at 37°C until an optical density of 0.2 was 
achieved at 540 run. The culture was then chilled on ice 
for 10 minutes before centrifugion for 10 minutes at 
6 000 rpm in a precooled rotor. Cells were resuspended
in 50 ml of ice-cold 50 mu CaClj and 10 mM Tris pH 8.
This cell suspension was placed in an ice bath for 15 minutes 
before being centrifuged again at 6 000 rpm for 10 minutes. 
Cells were resuspended in 6.6 ml of the ice-cold solution 
mentioned above. 0.2 ral aliquots of this suspension were 
dispensed in pre-chilled Eppendorf tubes and allowed to 
stand on ice for 1 hour. Plasmid was then added and the 
cells heat shocked at 42 U for 1 minute before 1 ml LB 
at 37°C was added. Samples were incubated at 37°C for 1 
hour to allow for phenotipic expression of transformants. 
Cells were then spun down and the supernatant discarded, 
cells were spread onto LA + 60 yug/ml ampicillin platei . 
Plates were incubated overnight at 37°C.
2.14. PREPARATION OF SAMPLES FOR RUNNING ON POLYACRYLAMIDE
5 ml of strains in T2 medium was grown up overnight. SOOjUl 
of this culture was spun down and the pellet resuspended 
in 20 mi fresh T2 medium. The culture was grown for 5-6 
hours and then challenged with 0, 1, 2, and 4 /ug/ml fusidic 
acid in 20 ml T2 medium. The challenged cultures were left 
to grow overnight at 28 °C. In vhe morning the cultures
■t
were spun down at 15 000 rpm for 20 minutes to obtain cell- 
free supernatants. The volume of each supernatant was 
measured and for each 1 ml of supernatant 0.66 g ammonium 
sulphate was added which resulted in 90% saturation. After 
this 0.1 g aliquots ammonium sulphates were added until 
the solution was completely saturated, this was done to 
precipitate the protein/s involved in fusidic acid 
inactivation. The supernatant was again spun at 15 000
rpm for 20 minutes and the pellet resuspended in 0.5 ml 
sterile distilled water. Once dissolved the sample was 
transferred to dialysis tubing and dialysed against 200- 
300 ml sterile distilled water for 3 - 6  hours. The samples 
were then frozen at -80°C for 15 minutes before being freeze- 
dried overnight.
2.15. AGAROSE GEL ELECTROPHORESIS
0.4% agarose gels were used. They were prepared by dissolving 
0.4 g agarose in 100 ml TBE (see Appendix). The solution 
was autoclaved before use. For each gel 25 ml of this 
solution was used to which 1.5 yul EtBr (10 mg/ml) was added 
before being poured. The electrophoresis buffer was TBE, 
250 ml TBE with 12.5 yUl EtBr (10 mg/ml) was used per gel. 
Gel loading buffer type III (see Appendix) was used in 
all instances. Gels were run at 80V in a minnie submarine 
model HE 33, and after completion were immediately observed 
on a UV transilluminator and photographed.
i.
2.16- SDS-POLYfiCRYLAMIDE GEL ELECTROPHORESIS 
Separating gels of 12.5% were used throughout and were 
always poured a day before the gel was to be run. The 
separating gel was kept moist and stored in the cold room 
overnight. The stacking gel was poured the following morning 
and allowed to polymerise for 2 hours before the gel was 
run. The s ■> sample loading buffer, electrophoresis buffer, 
stain and destain were used throughout (see Appendix). 
All gels were run at 120V for 3 - 5  hours. Gels were stained 
overnight and destained for 4 - 6  hours before being viewed 
on a illuminator and photographed.
t3. R E S U L T S  A M D  D I S C U S S I O N
3.1. ASSAYING FOR FUS1DIC ACID INACTIVATION IN MOCARDIOFORM 
BACTERIA
Plat? lysate and liquid assays (see 2.4, 2.4.1, 2.4.2)
were used for information of fusidic acid inactivation
in nocardioform wild-type and mutant strains. The mutant 
strains used throughout were : 01, derived from ATCC 12674, 
this 01 mutant has lost the plasmid-borne genes conferring 
resistance to sodium arsenate and arsenite, cadmium chloride, 
and chloramphenicol by curing of the plasmid (Dabbs and 
Sole, 1987). The second mutant 01(trp") was derived
ft urn 01 by nitrosoguanldine (NTG) mutagenesis. It is an 
auxotroph requiring tryptophan for growth on minimal medium 
and has an increased resistance to fusidic acid. Finally, 
01 (pro ) which was also derived from 01 by NTG mutagenesis, 
this auxotrophic mutant requires proline for growth on 
minimal medium and was more sensitive to fusidic acid than
Growth response to fusidic acid challenge
When actively growing cultures of the three mutants in 
exponential growth phase were challenged with 10 ug/ml 
fusidic acid, representative results showed that none of 
the strains had a clear demonstrative difference in growth 
response, (see Figure 1) for data see Table 1 in Appendix.
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Figure 1 : -
(Dato from Table 1.]
brown : OHpro ) 
red : OKtzp")
4:
Correlation of antibiotic phenotype and auxotrophv 
As OKtrp") had an increased fusidic acid resistance compared 
with 01, it was determined whether the increased fusidic
acid resistance was due to the mutation resulting in trp .
trp to trp’’ revertants were selected and uested. The
revertants were obtained by spreading an aliquot of an 
overnight culture of OKtrp- ) onto minimal media
plates. It was found that all revertants lost the increased 
resistance to fusidic acid and had the same phenotype on 
the assay plates as the parental 01 strain. The results 
therefore indicated that the mutation resulting in trp 
was probably responsible for the increased fusidic 
acid resistance, and that loss of the mutation results 
in loss of the fusidic acid resistance conferred by it.
pro to pro revertants could not be obtained suggesting
the possibility of a double mutation resulting in the pro” 
mutant.
Representative results clearly demonstrated that pro 
and trp strains inactivate fusidic acid at approximately 
the same rate. This suggested that the inactivating enzyme 
activity was the same or almost the same and that the 
resistant mutation of trp had nothing to do with 
the antibiotic inactivating system inherent in nocardioform 
bacteria.
3.1.1. INDUCIBILITy OF THE ANTIBIOTIC INACTIVATING SYSTEM 
Thf fusidic acid sensitive phenotype of 01, OKtrp")
, and OKpro ) was tested with and without the induction 
of the antibiotic inactivating system. The antibiotic
inackivadion mechanism of noci "dioform sctains is inducible, 
meaning that Che mechanism is only triggered upon induction 
by tusidic acid. The inactivating enzyme was only present 
in the supernatant of fusidic acid challenged cultures 
clearly demonstrating the inducibllity phenomenon. The 
strains were streaked onto TYA plates (uninduced) as well 
as TYA containing 0,25 /Jg/ml fusidic acid (induced) plates.
This concentration is sub-inhibitory but inducing. Plates 
were then incubated at 28°C overnight before samples were 
taken and spotted onto TYA plates with varying concentrations 
of fusidic acid. These induced and uninduced spot tests 
clearly gave different results (see Table 2).
Numerous assays revealed that the minimum concentration 
of fusidic acid needed to induce the cell-free inactivation 
system was l^ug/ml. Demonstrating that the inducible inactivatic 
enzyme is released into the supernatant. Results also indicated 
that for 01 and 01(trp") the cellfree inactivation system 
was hyperinducible, whereas Ol(pro’) was hypoinducible 
compared to the parental strain 01.
X>1
TABLE 2 (a) Spot test checking fusidic acid sensitive 
phenotype of 01, OKtrp ), and 
OKpro ) without the induction of the 
antibiotic inactivating system.
FUSIDIC ACID CONCENTRATION (yg/ml)
STRAIN 0 1 2 3 5 10 20
01(pro )
^  ^  ^  ^  ,
(b) Spot test checking fusidic acid sensitive 
phenotype of 01, OKtrp ), and 
01(pro ) with the induction of the 
antibiotic inactivating system.
FUSIDIC ACID CONCENTRATION (pg/ml)
STRAIN D 2 20
-H+ +++ + + + +++ +++ + + +
OKtrp") +++ +++ + + +
OKpro ) +++ ++
+ + + » maximum growth 
+ + = good growth
+ = poor growth
4
(a) Spot test checking fusidic acid sei 
phenotype of 01, OHtrp ), and 
OKpro ) without the induction of 1 
: inactivating system.
FUSIDIC ACID CONC1 ON (pg/»l)
STRAIN 3 30
Oltpro")
(b) Spot test checki
phenotype of 01, OKtrp ), and 
OKpro ) with the induction of 
antibiotic inactivating system.
FUSIDIC ACID CONCENTRATION (pq/ml)
3 5 10
OKtrp")
OKpro")
**
3.1.2. POLYACRYLAMIDE GEL ELECTROPHORESIS, TO VISUALIZE 
THE PUTATIVE INACTIVATING ENZYME/S 
Assays of cell-free supernatants clearly demonstrated that 
when cultures of the strains used were Induced with fusidic 
acid the inactivating enzyme was released into the 
supernatants, and that these supernatants could subsequently 
inactivate fusidic acid. Cell-free suspernatants of 01, 
Ol(trp ), and Ol(pro') were all able to inactivate 40 
ug/ml fusidic acid within 20 hours. Protein samples for 
electrophoresis were prepared as in section 2.14.
FIGURE 2 Protein samples of cell-free supernatants run 
on SDS-polyacrylamide gel to visualize putative 
inactivation enzyme/s 
Lane 1 : Protein molecular weight marker
Lane 2 : 01
Lane 3 : 0 1 + 1  ug/ml fusidic arid
Lane 4 : 0 1 + 2  ug/ml fusidic acid
Lane 5 : 0 1 + 4  ug/ml fusidic acid
Lane 6 : protein molecular weigh “j.
i3.1.3. LIQUID ASSAYS FOR FUS1DC ACID IMACTIVATION 
Numerous liquid assays (see 2.4.2) for both actively growing 
cultures and cell-free supernatants were carried out. This 
was because when plate assays of cell-free supernatants 
were done there was only a slight variation in the radius 
of the zones of inhibition versus large increments in the 
concentration of fusldic acid used, thereby making it 
impossible to construct a suitable graph for determining 
the rate of fusidic acid inactivation. Unfortuantely, 
although several assay organisms were used, namely, 
Arthrobacter oxidans, AD14, and ST47, both mutants derived 
from Escherichia coli, no suitable graphs of inactivation 
could be constructed. This was primarily because the fusidic 
acid standards of varying concentrations which were to 
be used for the calibration curve all grew up, became turbid, 
at the same or almost the same time, making it impossible 
to construct any meaningful calibration curve from which 
data could be extrapolated. With no other option available 
plate assays of cell-free supernatants were then done. 
Fusidic acid standards of various concentrations were 
prepared (see Table 3 (a) in Appendix). It was clear from 
preliminary experiments that for low concentration fusidic 
acid standards of between 0-1 ug/ml, assay plates would 
be incubated in the cold-room for 12 hours before being 
placed into the 2B°C room. This diffusion of the fusidic 
acid allowed for more accurate measuring of the zones of 
inhibition. For high concentration fusidic acid standards 
i.e. greater then 1 ug/ml, assay plates were placed directly 
into 28°C room. These conditions were optimal for measuring 
the zones of inhibition.

i.o-
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Figure 3 :-
Representotion of W &  acid (% /m l)  inactivation. Data as in 
Table 3a and 3b.
blue : 01
) and 01(pro )
" ' ■ 1 X
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3.1.4 ERYTHROMYCIN RESISTANT MUTANTS OP MOCARDIOFORM STRAINS 
LEAD TO INCREASED FUSIDIC ACID AND RIFAMPICIN 
RESISTANCE
High level erythromycin resistant mutants of ATCC 12674
as shown from numerous spot tests clearly had increased 
fusidic acid and rifampicin resistance when compared to 
the wild-type ATCC 12674 strain. When fusidic acid high 
level resistant mutants of ATCC 12674 were tested it was 
found that these had increased erythromycin and rifampicin 
resistance, and conversely, when rifampicin high level
resistant ATCC 12674 mutants were tested they had increased 
erythromycin and fusidic acid resistance. To determine 
whether this phenomenon is common in other nocardioform 
strains, 14887 and 4277 were tested in the same way and 
indeed the findings were the same, thereby leading to the
conclusion that this phenomenon was indeed common in 
nocardioform bacteria.
To determine whether the above situation also pertains 
to other gram-positive organisms, Bacillus subtilis strain 
1A3 was made high level erythromycin, fusidic acid, and 
rifampicin resistant and spot tested as before, but 
representative results were clear, there was no increased 
fusidic acid or rifampicin resistance.
From these results it appeared that in nocardioforms an 
amplification of a segment of DNA was taking place. Either 
it was an amplification of the genes of the target mo-^oules 
of the various antibiotics, namely, EF-G for fusidic acid, 
the beta subunit of RNA polymerase for rifampicin, and 
certain ribosomal proteins for erythromycin (Vazquez, 1979),
/
4-
or an amplification of the antibiotic inactivating genes 
involved in each case. Which of the two possibilities it 
is, is as yet not clear and still being investigated. For 
the purposes of this work, however, it would be beneficial 
if amplification of the inactivation genes has taken place 
as this would increase the number of copies of these genes, 
and thus enhance the ultimate aim of cloning the gene/s 
involved in fusidio acid inactivation.
3.2. MUTAGENESIS TO OBTAIN PUSIDIC ACID HYPERSENSITIVE 
NOCARDIOFORM MUTANTS (Crameri et al., 1986)
In nocardioform bacteria mutagenesis apparently occurs 
at a much lower rate than in Escherichia coli. The maximum 
frequency of auxotrophs produced, which was used as a 
meassure of the efficiency of mutagenesis- is approximately 
1-2% for nocart'.oforms. In Escherichia coli the frequency 
of auxothrophs can be greater than 80% (B.Dabbs Personal
Communication). This lack of mutant production could be 
explained by the lack of an error prone repair system in 
these organisms, another contributing factor is that 
nocardioform bacteria tend to clump. In order therefore 
to optimize mutagenesis the clumping phenomenon was reduced. 
T2 medium was used instead of TY for the growth of organisms 
and this reduced clamping as was shown by the fact that 
the colony forming units at a given optical density were 
higher. The clumping was further reduced, by approximately 
ten-fold, when samples were sonicated with a medium tip 
for 5 seconds after mutagenesis. The number of colonies 
increased by 50% when samples were vortexed for 80 seconds
before being spread onto TYA plates. Also 10 ® dilutions 
of samples were made before they were vortexed and spread 
onto plates, this was to ensure that single colonies would
To allow for the phenotypic expression of mutations, cultures 
were outgrown after the mutagenesis and this increased 
the risk of contamination. To overcome this problem strains 
used were made resistant to the aminoglycoside streptomycin 
which was then added to outgrowing cultures. 01 was thus 
made resistant to streptomycin and was the organism used 
for all mutagenesis experiments .
12
11
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59 - ultraviolet radiation for 10
IIn all mutagenesis experiments colonies that had grown 
up after a 10-6 dilution vortexed for 80 seconds had 
been spread onto TYA plates, were patched onto TYA, TYA 
+ 1 ,'jg/ml fusi.dic acid, and MM plates and screened. Colonies 
that grew up on TYA, but only grew poorly or not at all 
on MM plates were considered at auxotrophs. Those colonies 
growing readily on TYA, but not at all or poorly on TYA 
+ 1 pg/ml fusidic acid were considered as possible fusidic 
acid hypersensitive mutants i.e. candidates for mutants 
which have lost the fusidic acid inactivating gene/s due 
to mutational alterations. A number of fusidic acid 
hypersensitive mutants were wanted in order to examine 
the different complementation groups, as this is one way 
to make an assessment as to the number of gene/s involved 
in the nocardioform inactivation mechanism.
As no fusidic acid hypersensitive mutants were obtained 
from Oil a rifampicin resistant 01 strain was mede and 
designated as 012. When rifampicin sensitive mutants 
(isolated by Susan Anderson) were tested for fusidic acid 
sensitivity these mutants clearly still inactivated fusidic 
acid, indicating that the rifampicin and fusidic acid 
inactivating systems were different i.e. different genes 
are responsible.
nitrosoguanidine
t
/
■t
It is clear from the data in Table 5 that the only condition 
producing Cusidic acid hypersensitive mutants wat. NTG pH
4.a mutagenesis of a growing culture of 012. Representative 
results d« --strata i that the mutants were indeed 
hypersensitive to fusidic acid compared to the wildtype 
ATCC 12674 strain. The seven mutants were then placed in 
33% glycerol and frozen at -80aC. A possible explanation 
as to why no idic acid hypersensitive mutants could 
be obtained from the streptomycin resistant Oil strain 
will be given in the next section, 3.2.1.
3.2.1. GENETICS OF FUSIDIC ACID SENSITIVITY
The data presented above suggests that the streptomycin 
resistance mutation was responsible for not oeing able 
to produce fusidic acid hypersensitive mutants. ATCC 12674 
has two unstable genetic elements (Dabbs and Sole, 1987), 
o:":' which is lost spontaneously at a very low rate resulting 
in 01 and the other which can be cured with mitomycin C 
treatment. When curing strain Oil with mitomycin C, 
streptomycin resistance was reduced in two out of seven 
clones tested. The level of streptomycin resistance was, 
however, still higher than that of the parental strain, 
therefore two mutations are involved in the production 
of streptomycin resistance. One mutation may be chromosomal 
while the other is probably on the unstable genetic element 
which is cured by mitomycin C.
/Ribosomal protein S12 which is responsible for streptomycin 
resistance is co-transcribed with the EF-G gene which is 
the target of llusidic acid suggesting a close functional 
interaction between the two (personal communication E. 
Dabbs). The mutation in the S12 gene might result in an 
increased expression of SI 2 and thus also EF-G thus 
preventing the production of fusidic acid hypersensitive 
mutants.
3.3. ('iTIMl-'AU O N  OF TR' NSFORMAl, T 1 uN NOCARDIOFPRM
1IL'
01 was use) as ;> • recinient into rhich the plasmid pDA30 
was trsnsformec
3.3.1. NOC AM OV CPU ;f PANS FORMAT ION AND GROK TH PHASE 
OL.0L
Representa:i’e resu)"s (done in collabora . :on with Anne 
Daffey and O.iran Anders on) since cultures had to be sampled 
round the cock, demonstrated inat the growth phase of 
01 which resalted in the best tran^(c-matio ; efficiency 
was that termed as post-exponential, the absorbance reading 
of the cells at post-exponential growth phas.; (540 nm) 
was 3.89 (see Figure 4). In all transformation v.xperiments 
0.1 ug of plasmid pDA30 UZ!A was used. Each time cultures 
were sampled to give the results represented in Figure 
4, twenty 1 ml ciiqots vere taken and frozen ,.t -80°C. 
All future transformation experiments were thus per formed 
using toe frozen 01 cells with the optical dens.'t- r.f l.gS. 
For Odta to Figure 4 s-u Table 6 in Appendix.
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3.3.2. NOCARDIOFORM TRANSFORMATION EFFICIENCY BY 
VARYING THE AMOUNT OF PDA30 AMD CELLS (01)
In these experiments when the amount of plasr.iid was varied 
the amount of cells was kept constant and in all cases 
50 pi of cells was used. When the amount of cells was varied 
the amount of plasmid was kept constant and in all cased 
5 pi of plasmid DMA was used. 5Q%-polyethyleneglycol (PEG) 
was used throughout. 5 pi of pDA30 was equivalent to 0.1 
ug DNA. It is clear form the data presented in Figure 5 
that increasing the concentration of pDA30 DNA resulted 
in a decrease in the number of transformants per ug of 
pDA30 DNA, and hence a reduction in the efficiency of 
transformation. For data to Figure 5 see Table 7 in Appendix.
NoankkmTWmdm
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Representoth of the number o f transformants obtained with j
varyngpDtiO DMA volumes. |
blue s No. of transformants obtained with ljuKO.02>ig), 
3/ul(0.06pg), IfiUO.lipg), 9/jl(0.18pg) pDA30
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Volume o f 01 (-I)
figure fc -
Representoh'on of the iim ber of trarefomants/-g D 1  obtained with
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Prom the data’ in Figure 6 (for data to Figure 6 see Table 
6 in Appendix) it was apparent that increasing the volume 
of 01 cells resulted in a decrease in the number of 
transformants per ug DM. The combined data of Figure 5 
and Figure 6 clearly demonstrates that the condition which 
resulted in the most transformants per ug of pDA30 ON A 
was that in which 0.02 jig of pDA30 DNA was used, resulting 
in 350 transformants per jug of plasmid DNA.
To confirm that the recipient 01 strain had indeed been 
transformed with plasmid pDA30, four random transformants 
were taken. Plasmid minipreparations were performed on 
these transformants as well as 01 which would be the control. 
If transformation was successful then the plasmid pDA30 
should be present in all prepared samples except the 01 
control (see Figure 7). it is clear from the result in 
this Figure that in all cases pDA30 has been transformed
Plasmid pDA30
01 transformed with pDA30
01 transformed with pDA30 
01 transfox.,,ed with pDA30
with pDA30
43.4. CONSTRUCTION OF ft GENOMIC LIBRARY OF RHODOCOCCUS 
BQOI IN-THE ESCHERICHIA COLI RECIPIENT MM 294-1 
The first step was to ascertain whether the donor strain 
of Rhodococcus equi 14887/1 did indeed inactivate fusidic 
acid. This was necessary because if the strain did not 
inactivate fusidic acid its DMA could not be used for cloning 
by c'-nplementa-Aon as it would not have the fusidic acid 
inactivating gene/s, and could thus not complement the 
fusidic acid hypersensitive mutants of Rhodococcus 
arvthropolis into which its chromosomal DNA would be 
eventually transformed. The donor strain was thus grown 
up and challenged with 20 ug/ml fusidic acid, representative 
results demonstrated that after 10 hours all the fusidic 
acid had been completely inactivated. The chromosomal DNA 
of this strain could thus be used to build a library in 
MM294-1. The reason 14887/1 was used as the donor was, 
firstly, because a colleague was using the same strain 
for her work, to build up her library in MM294-1, which 
meant tha, our libraries could be shared. Secondly, it 
was necessary to use chromosomal DNA from various diffevent 
nocardioform strains to minimise recombination after 
transformation of this chromosomal DNA back into 
nocardioform, i.e. into the fusidic acid hypersensitive 
mutants, as a rec~ nocardioform mutant was not available.
The vector used to transform the chromosomal .DNA into 
MM294-1 was a putative shuttle vector made of pDA2 2 which 
is a nocardioform plasmid and pEcoR 251 which is r. suicide 
vector. The two plasmids were joined via their single Bam 
HI restriction sites.
/
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The putative shuttle vector pDA27 was constructed by Anne 
Daffey. The suicide vector has ampicillin resistance as 
well as EcoR 1 end-nuclease activity, a Bgl II restriction 
site lies within the EcoR 1 gene whose activity is suppressed 
by a lambda repressor. The chromosomal DNA fragments are 
inserted into the EcoR 1 gene by using Bgl II resulting 
in insertional inactivation of the gene, only transformants 
will thus grow on LA containing ampicillin plates. The 
nocardioform plasmid pDA22 has arsenate resistance and 
no Bgl II restriction site.

Plasmid pDA27 DNA maintained in E.coli and 14887/1 DMA 
were then extracted and purified (see Materials and Methods) ,
FIGURE 9 Gel showing puriEied pDA27 and 14887/1 
chromosomal DNA.
14887/1 chromoromal DNA 
14887/1 chromosomal DNA 
pDA27
/
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pDA27 and cHromosomal DNR was digested with restriction 
endonuclease Bgl II. Before restriction the concentrations 
of the respective DNA's was ascertained by absorbance
readings at 260 nm. pt)A27 had a concentration of 254 jug/ml,
and 14887/1 chromosomal DNA had a concentration of 295 
/ug/ml. pDA27 was restricted using 1.2 units of Bgl II for 
5 hours. Bgl II was used as there is only one Bgl II site 
and this is in the EcoR I gene of the pEcoR 251 plasmid, 
Bgl II was also used to restrict 14887/1 chromosomal DMA 
so that these fragments would insert into the EcoR gene
during ligation and result in insertional inactivation 
of this gene. After restriction the pDA27 samples were 
phenol extracted and ethanol precipitated to remove 
restriction endonuclease, and then resuspended in TE to
give a final concentration of 0.3 pg/ul DNA. This was then 
frozen at -80°C.
/*
Gel showing uncut and restricted pDA27 
uncut pDA27
/
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To dei-ermine Che condition which would result in the best 
partial digestion of 16887/1 chromosomal DMA a serial 
dilution series of Bgl II (12 units/ul) was done (see Figure 
11) .
FIGURE 11 Gel showing serial dilution series of Bgl II 
which was used to restrict the 14887/1 DMA 
for 3 hours.
Lane 1 - DMA molecular weight marker II
Lane 2 - 14887/1 DMA without Bgl II (cc -1)
Lane 3 - 14887/1 DNA plus * dilution ugl II
Lane 4 - 14887/1 DNA plus  ^dilution Bgl
Lane 5 •- 14887/1 DMA plus dilution Bgl
Lane 6 - 14887/1 DNA plus dilution Bgl
/
*
After observation of the gel it was decided that the 
10 ^ dilution of Bgl II gave the necessary result,
14887/1 DNA was then digested with this dilution of Bgl 
II. After restriction DNA was again phenol extracted and 
ethanol precipitated, and resuspended in TE to give a final 
concentration of 0.3 jug/ul DNA. Again this was frozen at
These DNA samples were then ligated and transformed into 
MM 294-1. The pDA27 concentration was kept constant, 0.3 
^g was used throughout. The 14387/1 chromosomal DNA 
concentration was varied to determine which concentration 
would give the most transformants, i.e. the best 
transformation efficiency. The ligated samples were 
transformed into MM 294-1 which is a xiSampicin resistant 
mutant of MM 294 in order to prevent any contamination 
in the library. This is because once the library was build 
up MM 294-1 could be grown up in the presence of rifampicin 
as well as ampicillin thereby inhibiting any contaminating 
organisms. A representative result is shown in Table 9.
TABLE 9 A presentation of the number of transformants
resistant to ampicillin with varying concentrations 
of 14887/1 chromosomal DNA.
Transformation sample Number of ampicillin^ 
transformants
MM 294-1 cells (control) 0
PDA27 0.3 pg o
0.3 ug pDA27 + 0.3 (ug 14887/1 DNA
0.3 ug pDA27 + 0.6 pg 14887/1 DNA
0.3 ug pDA27 + 1.2 pg 14887/1 DNA
0.3 ug pDA27 + 2.4 pg 14887/1 DKA
It was clear that 0.3 /ug pDA27 and 0.6 /ug chromosomal DMA 
yielded the highest number of transformants. This combination 
was thus used for all further transformation experiments.
A plasmid minipreparation was prepared on a random sample 
of six transformants. These samples were run on a 0.4% 
agarose gel to ascertain whether -.ransformation was 
successful. What one would expect to see was a gel showing 
pDA27 with chromosomal DNA inserts of various sizes (see 
Figure 12). After each transformation experiment the 
transformants were counted, then the transformants on each
■i
LA + 50 jUg/ml ampicillin plate were resuspended in 1 ml
LB + 60 jug/ml ampicillin, and transferred to a flask kept
at -80°C. Each batch of new transformants was added to
the same flask, and the addition was made at 80°C to prevent
cells from thawing. 1 2 3 4 5 6 7 8
FIGURE 12 Plasmid minipreparation of six random 
transformants showing chromosomal DNA 
inserts of various sizes.
Lane 1 - DNA molecular weight marker II 
Lane 2 - Cut pDA27
Lane 3 - pDA27 + chromosomal insert
Lane 4 - pDA27 + chromosomal insert
Lane 5 - pDA27 * chromosomal insert
Lane 6 - pDA27 + chromosomal insert
Lane 7 - pDA27 + chromosomal insert
Lane 8 - pDA27 + chromosomal insert
4Figure 12 shows a heterogeneous distribution of 14887/1 
chromosomal DMA inserts. Another plasmid minipreparation 
was performed on the same transformants and this was 
restricted overnight with Egl II. As pDA27 only has one 
Bgl II site in the EcoR 1 gene of the pBcoR 251 plasmid 
it was possible to excise the chromosomal D M  inserts that 
were inserted into the EcoR I gene (see Figure 13).
1 2 3 4 5 6 7 8
23130
9416
6557
4361
FIGURE 13 Gel showing chromosomal DNA fragments 
of various sizes after pDA27 had been 
digested with Bgl II overnight.
Lane 1 - DNA molecular weight marker II
Lane 3 - 14887/1 DNA fragments
Lane 4 - 14887/1 DNA fragments
Lane 5 - 14887/1 DNA fragments
Lane 6 - 14887/1 DNA fragments
Lane 7 - 14887/1 DNA fragments
Lane 8 - 14887/1 DNA fragments
analysis. A plot of
10 (b) in Appendix) average fragment 
rge a library is
L
4:
i.i-
41
3.2-
The average - fragment size as determined by regression 
analysis was 6 569 bp. At present a 14887/1 library of
3 500 transformants has been constructed.
A point has now been reached were fusidic acid hypersensitive 
mutants are available and a genomic library of 14887/1 
with 3 500 transformants has been constructed. The library 
of the putative shuttle vector containing the 14887/1 
chromosomal DMA inserts can be extracted from MM 294-1 
and t-ansformed into the fusidic acid hypersensitive mutants 
in an attempt to screen the fusidic acid inactivation gene/s 
by complementation.
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4A P P E N D I X  
T2 medium 
IS tryptone 
0,5% yeast extract 
3mM Sodium Chloride 
3mM Calcium Chloride 
lOmM Magnesium sulphate 
TY medium 
1% tryptone 
0,5% yeast extract 
LB (turia broth)
1% tryptone
0,5% yeast extract
0,5% N ad
TYG medium
1% tryptone
0,5% yeast extract
1% glycine
1% tryptone 
0,5% yeast extract 
1.5% agar
1% tryptone 
0,5% yeast extract 
0,5% NaCl 
1.5% agar
for assay plates H the concentration of agar was used.
ML
Minimal media (MM) plates
300 jiil of 10% Sodium glutamate 
(lOmg/ml) to flask (B) . Add
Cold detergent solution
SolUi 2
Solution 3
5 M KAc pH 8
P (protoplast) buffer
Sucrose 10,3 g
KgSOg 25 mg
HgCl2 6H20 0,202 g
87,5 ml distilled HgO
After autoclaving and before use add:
KH2P04 (0,5%) 1 ml 
CaCl2 2H20 (1M) 2,5 ml 
TBS buffer (pH 7.2) 10 ml
Regeneration plates 
for 500 ml : 0,9 g NaCl
3 g tryptone
1,5 g yeast extract 
35 g sucrose
add a little distilled HgO and beat up in a microwave 
for a few seconds at a time, until sucrose has dissolved. 
Then add 4 g agar and make up volume to 280 ml. After 
autoclaving add 6 ml 1 M CaCl2 and 10 ml TBS buffer 
(0,25 M pH 7.2). Plates can then be poured.
Gel loading buffer for agarose gels 
0,25% bromophenol blue 
30% glycerol in HgO
TBE Stock: 54 g Tris
Seperatinq gel for BPS - PAGE
14 ml 30% acrylamide-bisacrylamide stock
2 ml ammonium persulphate (10%); freshly prepared 
12 pi TEHED
Stacking gel for SDS - PAGE
6 pi TEMED
I .'
.. ■' 4
jLt . ,
For 1000 -1 of 5 x TBE Stock: 54 g Tris
27,5 g Boric acid 
20 ml 0,5 M BDTA
Seperatinq gel for SDS - PAGE
14 ml 30% acrylamide-bisacrylamide stock
20 ml 0.75 M Tris pH 8.8
0,4 ml 10% SDS
3,6 ml distilled H^O
2 ml ammonium persulphate {10%) i freshly prepared 
12 pi TEMED
Stacking gel for SDS - PAGE
3 ml 30% acrylamide-bisacrylamide stock 
10 ml 0,25 M Tris pH 6.8
0,2 ml 10% SDS
1 ml ammonium persulphate (10%), freshly prepared 
6 pi TEMED
Electrode buffer for SDS - PAGE
14,4 g glycine
33 ml 0,75 M Tris pH 8.8
10 ml 10% SDS
940 ml distilled HjO
Stain for SDS -PAGE
0,25 g coomasie brilliant blue R250 
125 ml methanol 
25 ml acetic acid 
100 ml distilled H^O
Destain for SDS - PAGE 
125 ml metjanol 
25 ml acetic 'acid 
100 ml distilled H^O
Sample loading buffer for SDS - PAGE 
10 ml 0,25 M Tris pK 6.8 
8 ml 10$ SDS 
4 ml glycerol 
2 ml - mercsptoethanol 
16 ml distilled H^O 
0,0004 g bromophenol blue 
Ligation buffer
200 mM Tris-HCl 
100 mM MgClg 
100 mM DTT 
0,6 mM ATP 
This was made up
0,6 ml pH 7.6
:o 10 ml with starile distilled H.O.
I
i01 Ol(trp-) 01(pro-)
adding
lb)
adding
<h)
0
2 0,4-72 2
4 0,614 4
8 0,737 0,717
1 tig/ml)
s Zones of inhibition
0,2
0,9
»
1,1'
Table 3 - (b) Fusidic acid (5 ul/ml) inactivation by
01, 01(trp ) and 01(pro ) cell free 
supernatants after various times as 
. assayed on IA + 30 ug/ml rifampicin 
plates matted with a lawn of C7R.
OKtrp") 01(pro )
Zone of 
inhibition
Zone of 
inhibition
Zone of 
Time inhibition
0 0 0 1,3
30 30 30 0,8
60 60 60 0,5
90 no zone 90 no«on«
120 no tone no zone 120 no tone
no zone - implies that all the fusidic acid has been 
inactivated.
Table 6 - Nocardioform transformation
?ime (h) Absorbance (540 nm) Number of transformants/
pig DNA
-i"
:$•
i
t^ l)
I (0,02 ,ug) 7
3 (0,06 pg) 9
7 (0,14 pgt 12
9 (0,16 jug) IS 84
i,'r' ' /
X - X y y (x-?)(y-y) (x - x)2 y t*
.4 3.75 -15
-15 0 0 - 5
- 7 -0.2 1.4 49 - 5
4 -0.4 -1.6 4
22 23
25
5  42.9 S  2299
b = (x - x) ( v - v)
(x - x)2 
b = 0,019
ragment size) = y + b (x - x)
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